PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity
Clinical trial NCT06199427 · RECRUITING
Trial details
- NCT number
- NCT06199427
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-21
- Primary completion
- 2026-11-21
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.